EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
-2.99%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$901M
AUM Growth
+$901M
(-4.9%)
Cap. Flow
+$15.1M
Cap. Flow
% of AUM
1.68%
Top 10 Holdings %
Top 10 Hldgs %
59.92%
Holding
81
New
8
Increased
30
Reduced
17
Closed
13
Top Buys
| 1 |
HealthEquity
HQY
|
$24.7M |
| 2 |
Inspire Medical Systems
INSP
|
$21.9M |
| 3 |
GSK
GSK
|
$13.7M |
| 4 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$12.8M |
| 5 |
Elevance Health
ELV
|
$8.44M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$31.2M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
$15.5M |
| 3 |
Icon
ICLR
|
$12.5M |
| 4 |
ABCM
Abcam plc American Depositary Shares
ABCM
|
$12.2M |
| 5 |
Amneal Pharmaceuticals
AMRX
|
$11.1M |
Sector Composition
| 1 | Healthcare | 99.84% |
| 2 | Communication Services | 0% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Humana
HUM
$37.5B
| $8.82M | 0.75% |
18,121
+6,194
| +52% | +$3.01M |
|
|
AMRN
27
Amarin Corp
AMRN
$311M
| $7.76M | 0.66% |
8,431,875
-2,070,234
| -20% | -$1.9M |
|
28
Viridian Therapeutics
VRDN
$1.59B
| $6.8M | 0.58% |
+443,270
| New | +$6.8M |
|
29
Waters Corp
WAT
$17.3B
| $6.34M | 0.54% |
23,124
+12,196
| +112% | +$3.34M |
|
30
NewAmsterdam Pharma
NAMS
$2.8B
| $6.11M | 0.52% |
660,618
-31,751
| -5% | -$294K |
|
|
TSVT
31
DELISTED
2seventy bio
TSVT
| $5.7M | 0.48% |
+1,453,378
| New | +$5.7M |
|
32
Seres Therapeutics
MCRB
$162M
| $5.6M | 0.47% |
2,352,556
-724,200
| -24% | -$1.72M |
|
33
Taysha Gene Therapies
TSHA
$791M
| $5.39M | 0.46% |
+1,705,774
| New | +$5.39M |
|
34
InflaRx
IFRX
$117M
| $5.18M | 0.44% |
1,737,544
-177,569
| -9% | -$529K |
|
|
35
Icon
ICLR
$14B
| $5.17M | 0.44% |
20,998
-50,728
| -71% | -$12.5M |
|
36
Protagonist Therapeutics
PTGX
$3.62B
| $4.78M | 0.4% |
286,748
+172,089
| +150% | +$2.87M |
|
37
Agilent Technologies
A
$35.5B
| $4.68M | 0.4% |
41,825
+13,365
| +47% | +$1.49M |
|
38
Apellis Pharmaceuticals
APLS
$3.51B
| $4.67M | 0.39% |
122,643
+66,194
| +117% | +$2.52M |
|
39
IQVIA
IQV
$31.4B
| $4.53M | 0.38% |
23,041
+4,293
| +23% | +$845K |
|
40
Maravai LifeSciences
MRVI
$341M
| $4.52M | 0.38% |
+452,323
| New | +$4.52M |
|
41
Puma Biotechnology
PBYI
$258M
| $4.42M | 0.37% |
1,681,149
+22,954
| +1% | +$60.4K |
|
42
Pennant Group
PNTG
$853M
| $4.07M | 0.34% |
365,899
-65,723
| -15% | -$731K |
|
43
Molina Healthcare
MOH
$9.6B
| $4.01M | 0.34% |
12,234
-9,020
| -42% | -$2.96M |
|
44
Gossamer Bio
GOSS
$587M
| $3.69M | 0.31% |
4,427,857
+3,678,160
| +491% | +$3.06M |
|
45
Revvity
RVTY
$9.68B
| $3.62M | 0.31% |
32,698
+11,384
| +53% | +$1.26M |
|
46
CureVac
CVAC
$1.21B
| $3.53M | 0.3% |
516,794
+159,452
| +45% | +$1.09M |
|
47
Biohaven
BHVN
$1.71B
| $3.41M | 0.29% |
131,103
| – | – |
|
48
Insulet
PODD
$24.2B
| $3.4M | 0.29% |
+21,299
| New | +$3.4M |
|
49
Merus
MRUS
$5.04B
| $3.16M | 0.27% |
134,010
+2,784
| +2% | +$65.6K |
|
50
Sutro Biopharma
STRO
$85.6M
| $2.67M | 0.23% |
769,638
+21,726
| +3% | +$75.4K |
|